Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery
Subtenon Versus Intravenous Dexmedetomidine for Postoperative Analgesia and Vomiting Control in Infantile Cataract Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of the present study was to evaluate the efficacy and safety of subtenon block (SB)anesthesia with dexmedetomidine in combination with bupivacaine versus intravenous dexmedetomidine for postoperative analgesia and emesis control in infants undergoing cataract surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 postoperative-pain
Started Jul 2015
Longer than P75 for phase_2 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 3, 2015
CompletedFirst Posted
Study publicly available on registry
July 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedJanuary 27, 2017
January 1, 2017
2.3 years
July 3, 2015
January 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative assessment for number of infants requiring rescue analgesia and rescue antiemetics
by analysis for number of infants withCRIES pain scale score \>3
4 hours postoperatively
postoperative CRIES pain scale score
(0-2 for each parameter)
4 hours postoperatively
Secondary Outcomes (2)
vomiting scale score
4 hours postoperative
Number of oculocardiac reflex(OCR)events(acute reduction in heart rate of >20%).
intraoperative period
Study Arms (2)
subtenon block Group (SB)
EXPERIMENTALreceived SB block with 0.05 mL/kg of 0.5%bupivacaine and 0.5µ/kg dexmedetomidine mixture
intravenous dexmedetomidine Group(IV)
EXPERIMENTALreceived 1µ/kg IV dexmedetomidine after induction of anesthesia
Interventions
SB block with 0.05 mL/kg of 0.5%bupivacaine and 0.5µ/kg dexmedetomidine mixture
received 1µ/kg IV dexmedetomidine
Eligibility Criteria
You may qualify if:
- ASA physical status grade I and II infants (1-12month).
- undergoing elective cataract surgery in one eye under general anesthesia.
You may not qualify if:
- infection of the orbit,
- increased intraocular pressure(IOP),
- history of allergy to local anesthetics,
- history of previous eye surgery,
- cardiovascular or clotting disorders,
- full stomach,inner ear disorders or other conditions predisposing to vomiting
- airway abnormalities
- compromised sclera.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut Univeristy Hospital
Asyut, 71515, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor in anesthesia and intensive care department,faculty of medicine assiut university
Study Record Dates
First Submitted
July 3, 2015
First Posted
July 13, 2015
Study Start
July 1, 2015
Primary Completion
November 1, 2017
Study Completion
November 1, 2017
Last Updated
January 27, 2017
Record last verified: 2017-01